The predominant expression of RANBP9 over RANBP10 in NSCLC correlates with increased proliferation in both NSCLC cell lines and patients, where increased expression of RANBP10 resulted in a reduction in cell proliferation and in the level of proteins involved in cell proliferation. The gene discussed is RANBP9; the disease is non-small cell lung carcinoma.